Hisamitsu Pharmaceutical Co., Inc. (HTSUF)

HTSUF Ratios and Metrics

Market cap in millions USD. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 20, 2025	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Market Capitalization	2,886	2,050	1,958	2,231	2,576	5,089
Market Cap Growth	33.23%	4.67%	-12.22%	-13.40%	-49.37%	40.13%
Enterprise Value	2,197	1,309	1,155	1,157	1,362	3,859
Last Close Price	29.00	23.95	33.16	30.02	34.15	41.01
PE Ratio	22.55	14.16	21.01	25.86	30.75	58.67
PS Ratio	2.83	1.98	2.07	2.37	2.47	4.74
PB Ratio	1.66	1.10	1.10	1.18	1.17	2.14
P/TBV Ratio	1.71	1.14	1.14	1.19	1.18	2.16
P/FCF Ratio	-	59.96	55.74	62.38	19.05	278.60
P/OCF Ratio	-	16.42	16.13	23.86	15.47	102.61
EV/Sales Ratio	2.11	1.26	1.22	1.23	1.31	3.59
EV/EBITDA Ratio	12.88	7.80	9.44	9.52	11.50	27.90
EV/EBIT Ratio	17.77	10.41	13.15	13.58	16.82	38.57
EV/FCF Ratio	-	38.30	32.88	32.35	10.07	211.27
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	-	0.15	0.11	0.14	0.18	0.11
Debt / FCF Ratio	-	0.75	0.40	0.47	0.16	0.82
Asset Turnover	0.47	0.46	0.44	0.42	0.40	0.38
Inventory Turnover	2.64	2.98	3.13	3.15	2.87	2.67
Quick Ratio	3.07	3.73	3.66	4.15	5.61	5.83
Current Ratio	3.77	4.32	4.22	4.68	6.22	6.59
Return on Equity (ROE)	-	8.16%	5.49%	4.72%	3.88%	3.74%
Return on Assets (ROA)	-	3.52%	2.56%	2.35%	1.94%	2.20%
Return on Invested Capital (ROIC)	11.38%	9.86%	7.40%	7.31%	6.07%	7.18%
Return on Capital Employed (ROCE)	6.30%	6.40%	4.70%	4.30%	3.40%	4.00%
Earnings Yield	4.43%	7.06%	4.76%	3.87%	3.25%	1.70%
FCF Yield	-	1.67%	1.79%	1.60%	5.25%	0.36%
Dividend Yield	2.44%	2.39%	1.71%	2.06%	2.13%	1.91%
Payout Ratio	-	29.96%	47.09%	57.22%	70.81%	73.58%
Buyback Yield / Dilution	3.92%	4.27%	3.03%	2.29%	0.63%	0.56%
Total Shareholder Return	6.37%	6.65%	4.74%	4.35%	2.77%	2.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.